Objectives: New Delhi MBL (NDM) is a type of carbapenemase; 20 variants of NDM have been identified to date. We have found a new variant of NDM, NDM-21, and describe it here.
Introduction
New Delhi MBL (NDM) is a type of carbapenem-hydrolysing enzyme (carbapenemase) conferring resistance to all clinically available b-lactams except monobactams such as aztreonam. 1 NDM was first found in a Klebsiella pneumoniae isolate in 2008 2 and since then bacterial isolates producing NDM have been found worldwide, representing a serious challenge for treatment, infection control and public health. Twenty variants of NDM are known so far, with NDM-1 and NDM-5 being particularly widespread. [3] [4] [5] [6] We have found a gene encoding a new variant of NDM, NDM-21, in an Escherichia coli clinical isolate and report it here.
Materials and methods
Strain and susceptibility tests E. coli strain SCEC020023 was recovered from the urine of a 34-year-old female patient with diabetes in a hospital in Yibin City, Sichuan Province, southwest China, in October 2016. The patient had hydronephrosis and ureterectasis due to ureter stones and developed a catheter-related urinary tract infection, from which strain SCEC020023 was recovered. The patient had fully recovered after removal of the urinal catheter without using antimicrobial agents. MICs of amikacin, aztreonam, aztreonam/avibactam, ceftazidime, ceftazidime/avibactam, ciprofloxacin, colistin, imipenem, meropenem, piperacillin/tazobactam, tigecycline and trimethoprim/sulfamethoxazole were determined using the broth dilution method of CLSI. 7 As CLSI has no breakpoints for colistin and tigecycline, those defined by EUCAST (http://www.eucast.org/) were applied.
Genomic sequencing and analysis
Genomic DNA of strain SCEC020023 was prepared using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) and was subjected to WGS using the Illumina HiSeq X10 platform (Illumina, San Diego, CA, USA). The short reads generated were de novo assembled into contigs using SPAdes. 8 ST was determined using the genomic sequence to query the E. coli MLST database (http:// enterobase.warwick.ac.uk/species/index/ecoli). Antimicrobial resistance To obtain the complete sequence of the plasmid carrying bla NDM-21 , strain SCEC020023 was subjected to sequencing using the long-read MinION Sequencer (Nanopore, Oxford, UK). The de novo hybrid assembly of both short Illumina reads and long MinION reads was performed using Unicycler v0.4.3 9 under conservative mode for increased accuracy. Complete circular contigs generated were then corrected using Pilon v1.22 10 with Illumina reads for several rounds until no change was detected.
The draft whole-genome sequence of strain SCEC020023 has been deposited in GenBank under the accession number PDDR00000000. The complete sequences of pNDM21_020023 and pRmtB_020023 have been deposited in GenBank under the accession numbers CP025948 and CP025949, respectively.
Phylogenetic PCR
The phylogenetic group was determined using PCR as described previously.
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Cloning of bla NDM-21 and bla The complete coding sequences of bla NDM-21 and bla NDM-5 with their natural promoters were amplified with self-designed primers NDM-upn (TTGAAACTGTCGCACCTCAT) and NDM-dw (CTGGGTCGAGGTCAGGATAG) using PrimeSTAR Max DNA Polymerase (Takara, Dalian, China) from strains SCEC020023 and WCHECLL123, respectively. Strain WCHECLL123 is an ST206 E. coli 12 from which bla NDM-5 was cloned as a control. Amplicons were ligated to the pMD20-T vector using the Mighty TA-cloning Kit (Takara). The ligated fragments were transformed into E. coli DH5a. bla NDMcontaining transformants were selected on LB agar plates containing 4 mg/L meropenem. The presence of bla NDM-21 or bla NDM-5 in transformants was confirmed by PCR and Sanger sequencing. MICs of imipenem, meropenem, ertapenem, piperacillin/tazobactam, ceftazidime and aztreonam were determined for transformants carrying bla NDM-21 or bla NDM-5 using the broth microdilution method. 7 
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Conjugation experiments were carried out in broth and on filters with the azide-resistant E. coli strain J53 as the recipient. Transconjugants were selected on LB agar plates containing 4 mg/L meropenem and 150 mg/L azide and the presence of bla NDM-21 in transconjugants was confirmed by PCR and Sanger sequencing. WGS using the Illumina HiSeq X10 platform generated 6 092 382 clean reads and 1.83 Gb clean bases. A total of 149 contigs (116 .1000 bp; N50 104479 bp) with a 50.76% GC content were de novo assembled. Strain SCEC020023 belonged to phylogenetic group A and ST617. Strain SCEC020023 had a new bla NDM variant, which is 99.9% identical to bla NDM-5 with only a single nucleotide difference (G205A) encoding an amino acid substitution (G69S) compared with NDM-5. This new NDM enzyme has been assigned the name NDM-21 by the Pathogen Detection group of GenBank, National Center for Biotechnology Information. In addition, the strain had 12 antimicrobial resistance genes mediating resistance to aminoglycosides [aph(3')-IIa, aadA1, rmtB], b-lactams (bla CTX-M-55 , bla OXA-10 , bla TEM-1b ), phenicol (cmlA1, floR), rifampicin (arr-2), tetracycline [tet(A)], sulphonamides (sul2) and trimethoprim (dfrA14). bla NDM-21 was able to be transferred by conjugation with 10
Results and discussion
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(transconjugant/recipient) efficiency, suggesting that it was carried by a self-transmissible plasmid. The hybrid assembly of Illumina and MinION reads revealed that bla NDM-21 was carried on a 46.1 kb IncX3 plasmid, which is assigned the name pNDM21_020023 here. bla NDM-21 and ble (mediating bleomycin resistance) are the only antimicrobial resistance genes present on pNDM21_020023. pNDM21_020023 is almost identical (100% coverage and 99% identity) to a number of previously described IncX3 plasmids carrying bla NDM-5 , including pNDM_MGR194 (GenBank accession number KF220657) of K. pneumoniae strain MGR-K165 from India. The differences between pNDM21_020023 and pNDM_MGR194 include the absence of a 93 bp repeat sequence in the spacer region between taxD (encoding DNA distortion protein 3) and repA (encoding the replication initiation protein) and a few SNPs, which were dispersed across the plasmid sequence. The nearly identical plasmid sequence is indicative of inter-species transfer of this IncX3 plasmid. The genetic context of bla NDM-21 is identical to that of bla NDM-5 on pNDM_MGR194 ( Figure 1 ). In such contexts, bla NDM-5 and bla NDM-21 are downstream of an IS, ISAba125, which is interrupted by the insertion of IS5 and is also truncated by the insertion of IS3000 at its left end (upstream). Several genes that are usually present with bla NDM-5 are located downstream of bla NDM-5 and bla NDM-21 . These genes are ble (mediating bleomycin resistance), trpF (encoding a phosphoribosylanthranilate isomerase), dsbC (encoding an oxidoreductase) and ctuA1 (encoding an ion-tolerant protein), which is truncated by the insertion of IS26. The regions containing bla NDM-5 and bla NDM-21 are present between mpr (encoding a zinc metalloproteinase) and a truncated umuD (encoding a mutagenesis protein), both of which belong to the IncX3 plasmid backbone (Figure 1 ). The identical genetic context would support the hypothesis that bla NDM-21 has evolved directly from bla NDM-5 via a point mutation on this IncX3 plasmid. Transformants carrying bla NDM-21 or bla NDM-5 were obtained. The MICs of imipenem, meropenem and ertapenem for DH5a transformants containing bla NDM-21 were 128, 128 and 64 mg/L, respectively (Table 1 ), which were identical or similar to those for DH5a containing bla NDM-5 . This suggests that the amino acid substitution of NDM-21 has not altered its activity against carbapenems compared with NDM-5. The prototype NDM enzyme, NDM-1, has 5 a-helices and 11 antiparallel b-strands and contains five active site loops. 13 The G69S amino acid substitution in NDM-21 occurs in the first active site loop between strands b2 and b3, which shifts away from the Zn centre to accommodate substrates with varying molecular conformations. 13 Compared with NDM-1, NDM-5 has two amino acid substitutions, V88L and M154L, both of which do not belong to any active site loops of NDM enzymes, but it has increased activity against carbapenems. 3 In contrast, NDM-21 has an amino acid substitution in the active site loop but this A new variant of bla NDM JAC does not alter its activity against carbapenems. Therefore, it would appear that whether a substitution occurs in or out of the active site loops is not necessarily associated with the activity of NDM enzymes against carbapenems.
bla CTX-M-55 and rmtB were carried by a 73 313 bp IncFII plasmid, which belonged to the FII33 type. Both bla CTX-M-55 and rmtB were located in an 8067 bp region that was flanked by IS26. There was an additional IS26 between bla CTX-M-55 and rmtB in the region. Any two of the three copies of IS26 could form composite transposons to mediate the intervening genetic components. However, no 9 bp direct target repeats were present flanking any two copies of IS26, suggesting the region containing bla CTX-M-55 and rmtB may have been formed by recombination.
Conclusions
We report a new variant of NDM, NDM-21, which has a G69S amino acid substitution compared with NDM-5. NDM-21 has the same activity against carbapenems as NDM-5. The encoding gene bla NDM-21 is carried by a self-transmissible IncX3 plasmid from an E. coli clinical isolate in China. Liu et al.
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